Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Aliment Pharmacol Ther. 2011 Nov 30;35(2):255–265. doi: 10.1111/j.1365-2036.2011.04926.x

Figure 1.

Figure 1

Baseline and subsequent serum alkaline phosphatase (AP) levels over the course of treatment. Significant reductions in serum AP levels are observed at 9 and 12 months.